The tumor volumes were significantly decreased in Oct-4 siRNA-treated LC-CD133+ when exposed to IR alone, cisplatin alone, or IR combined with cisplatin (p<0.01; Fig. 7A). The gene discussed is POU5F1; the disease is neoplasm.